AEON GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
AEON Biopharma Inc - Class A
Exchange: NYSE MKTSector: HealthcareIndustry: Biotechnology
Priveterra Acquisition Corp - Class A
Did you know?
Price sits at 49% of its 52-week range.
Current Price
$0.89
-9.16%Profile
Valuation (TTM)
Market Cap$10.52M
P/E-0.27
EV—
P/B—
Shares Out11.84M
P/Sales—
Revenue$0.00
EV/EBITDA—
AEON Biopharma Inc - Class A (AEON) Quality Analysis
AEON Profitability
Profitability trend analysis coming soon
AEON Growth
Growth trend analysis coming soon
AEON Financial Health
Financial health indicators coming soon
AEON Quality & Fundamental Analysis
AEON Biopharma Inc - Class A (AEON) is a Healthcare company in the Biotechnology industry, listed on NYSE MKT. This quality analysis page evaluates AEON Biopharma Inc - Class A's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
AEON Biopharma Inc - Class A has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency.. Return on assets (ROA) stands at -705.43%.
with a current ratio of 0.49.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether AEON Biopharma Inc - Class A is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.